Latest European Union News

GreenX Metals has identified the Mid-European Crystalline Zone beneath the historic Richelsdorf copper mines in Germany, revealing a likely primary source of copper mineralisation and significantly boosting exploration potential at its Tannenberg Project.

Compumedics has secured FDA clearance for its single-use Somfit®D device, effectively doubling its addressable U.S. home sleep testing market to an estimated US$240 million annually. This milestone positions the company to capture significant market share with a dual-platform EEG-based solution.

Prospech Limited has announced a pro-rata renounceable entitlement offer aiming to raise up to $1.62 million to fund metallurgical testing and exploration at its Korsnäs rare earth elements project in Finland. The offer is partially underwritten and includes attaching options, reflecting the company’s ongoing development efforts and funding needs.

Imricor Medical Systems has taken a significant step toward U.S. market entry by submitting its Vision-MR Diagnostic Catheter for FDA 510(k) approval, complementing its recent NorthStar system filing. These moves aim to establish a fully integrated MRI-guided cardiac ablation platform.

Osteopore Limited reported a 6% increase in revenue to $1.56 million for the half-year ended June 2025, alongside a slight rise in net loss driven by expanded product development and compliance costs. The company secured key regulatory approvals and broadened its distribution footprint in Asia and the US.

Evion Group’s joint venture in India has made its inaugural shipments of expandable graphite to the US, capitalizing on rising global demand and supply shortages. The company also secures EU recognition as a preferred graphite supplier for critical industries.

Sprintex Limited reported a 26% revenue increase for FY25 but also a 37% rise in net loss, as it accelerates global expansion through key distribution deals and manufacturing upgrades.

DroneShield Limited has reported a record half-year performance with revenues soaring 210% to A$72.3 million and a robust sales pipeline exceeding A$2.3 billion, underpinned by rising global defense spending and advanced AI counterdrone technology.

Imricor Medical Systems reported a sharp 52% revenue decline and a 92% increase in net loss for H1 2025, offset by a $42.8 million equity raise boosting liquidity. The company is investing heavily in European sales and clinical trials while pursuing FDA approval.

Argent BioPharma has signed a binding term sheet to acquire key assets from AusCann Group Holdings, significantly expanding its clinical pipeline, intellectual property, and European manufacturing and distribution capabilities ahead of a planned US stock exchange listing.

Sarytogan Graphite Limited secures a strategic A$3.6 million investment from Kazakh high-net-worth investor Dias Sarsenov, accelerating its Definitive Feasibility Study for a critical graphite project vital to Europe’s raw materials supply.

European Metals Holdings has secured a crucial funding pathway to complete the Definitive Feasibility Study for its Cinovec Lithium Project, combining a A$3 million placement with non-dilutive refinancing options to meet its €5.39 million share of a €11 million cash call.